BioSciences Corp and Mab-Venture announce development/commercialisation deal

Feb 10, 2018

Californian HQ’d BioSciences Corp & Shanghai based Mab-Venture announce a deal under which Mab-Venture will develop and manufacture biosimilars and BioSciences Corp will commercialise (through partners) those products in India, SAARC, MENA, Turkey, LatAm and Russia. The deal covers “multiple” products which have not been named.  Read more

Print Page Mail Article